Evidence map›Paper›PMID 39384783›Full record

ArticleNature communications2024

Author Correction: Targeting HDAC6 to treat heart failure with preserved ejection fraction in mice.

Sara Ranjbarvaziri, Aliya Zeng, Iris Wu, Amara Greer-Short, Farshad Farshidfar, Ana Budan, Emma Xu, Reva Shenwai, Matthew Kozubov, Cindy Li and 9 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Sara Ranjbarvaziri *Tenaya Therapeutics, South San Francisco, CA, USA.
Aliya Zeng *Tenaya Therapeutics, South San Francisco, CA, USA.
Iris WuTenaya Therapeutics, South San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-7515-4766
Amara Greer-ShortTenaya Therapeutics, South San Francisco, CA, USA.
Farshad FarshidfarTenaya Therapeutics, South San Francisco, CA, USA.
Ana BudanTenaya Therapeutics, South San Francisco, CA, USA.
Emma XuTenaya Therapeutics, South San Francisco, CA, USA.
Reva ShenwaiTenaya Therapeutics, South San Francisco, CA, USA.
Matthew KozubovTenaya Therapeutics, South San Francisco, CA, USA.
Cindy LiTenaya Therapeutics, South San Francisco, CA, USA.
Melissa Van PellTenaya Therapeutics, South San Francisco, CA, USA.
Francis GraftonTenaya Therapeutics, South San Francisco, CA, USA.
Charles E MacKayTenaya Therapeutics, South San Francisco, CA, USA.
Xiaomei SongTenaya Therapeutics, South San Francisco, CA, USA.
James R PriestTenaya Therapeutics, South San Francisco, CA, USA.
Gretchen ArgastTenaya Therapeutics, South San Francisco, CA, USA.
Mohammad A MandegarTenaya Therapeutics, South San Francisco, CA, USA.
Timothy HoeyTenaya Therapeutics, South San Francisco, CA, USA.
Jin YangTenaya Therapeutics, South San Francisco, CA, USA. flairjinyang@gmail.com.ORCID http://orcid.org/0000-0001-8985-1319

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39384783
PMCPMC11464698

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.